Daten werden ergänzt – lade die Seite später neu, um den aktuellen Stand zu sehen
5560-77-0CN(C)CCO[C@@H](c1ccc(Cl)cc1)c1ccccn1OJFSXZCBGQGRNV-INIZCTEOSA-N(S)-carbinoxamine is the (S)- (active) enantiomer of carbinoxamine. It is an enantiomer of a (R)-carbinoxamine.
5560-77-0Sicherheitsangaben dienen nur zur Orientierung und ersetzen weder das Sicherheitsdatenblatt (SDB) des Lieferanten noch geltende Vorschriften oder eine fachliche Bewertung.
Carbinoxamine competes with free histamine for binding at HA-receptor sites. This antagonizes the effects of histamine on HA-receptors, leading to a reduction of the negative symptoms brought on by histamine HA-receptor binding. Carbinoxamine's anticholinergic action appears to be due to a central antimuscarinic effect, which also may be responsible for its antiemetic effects, although the exact mechanism is unknown.
For symptomatic relief of seasonal and perennial allergic rhinitis and vasomotor rhinitis, as well as allergic conjunctivitis caused by foods and inhaled allergens. Also for the relief of allergic reactions to blood or plasma, and the symptomatic management of mild, uncomplicated allergic skin manifestations of urticaria and angioedema.
VerwendenAntihistaminic.
DefinitionChEBI: The (S)- (active) enantiomer of carbinoxamine.
DTXSID40204146CHEMBL1740361CHEBI:59329